Concord Healthcare Group Co., Ltd. (HKG:2453)
Hong Kong · Delayed Price · Currency is HKD 0.9000
+0.0200 (2.27%)
Jun 5, 2026, 4:09 PM HKT
Concord Healthcare Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 459.92 | 388.31 | 538.65 | 472.17 | 470.51 | |
Revenue Growth (YoY) | 18.44% | -27.91% | 14.08% | 0.35% | 182.89% |
Cost of Revenue | 427.92 | 455.57 | 603.71 | 614.77 | 517.62 |
Gross Profit | 32 | -67.26 | -65.06 | -142.6 | -47.11 |
Selling, General & Admin | 186.58 | 259.36 | 247.16 | 274 | 305.56 |
Research & Development | 28.17 | 31.18 | 36.44 | 41.32 | 40.38 |
Other Operating Expenses | -16.18 | -3.62 | -0.77 | -7.76 | 47 |
Operating Expenses | 220.47 | 300.34 | 291.74 | 327.2 | 392.93 |
Operating Income | -188.47 | -367.6 | -356.79 | -469.8 | -440.05 |
Interest Expense | -123.53 | -109.27 | -108.01 | -274.48 | -435.31 |
Interest & Investment Income | 0.68 | 0.73 | 7.28 | 7.79 | 5.47 |
Earnings From Equity Investments | -3.82 | -1.31 | -1.74 | -0.22 | -0.16 |
Currency Exchange Gain (Loss) | 1.82 | -1.09 | -0.04 | -0.64 | 0.56 |
Other Non Operating Income (Expenses) | 4.07 | -66.15 | 26.8 | 41.68 | - |
EBT Excluding Unusual Items | -309.25 | -544.69 | -432.49 | -695.67 | -869.49 |
Gain (Loss) on Sale of Investments | 0.15 | 7.56 | - | - | - |
Gain (Loss) on Sale of Assets | 0.51 | 40.07 | - | -1.13 | 29.89 |
Asset Writedown | -2.67 | -0.54 | -0.25 | -0.77 | - |
Other Unusual Items | 1.24 | 11.74 | 0.14 | 50.4 | 3.27 |
Pretax Income | -310.02 | -485.85 | -432.59 | -647.17 | -836.34 |
Income Tax Expense | -4.23 | -1.03 | -6.2 | -9.95 | -5.2 |
Earnings From Continuing Operations | -305.8 | -484.82 | -426.39 | -637.22 | -831.13 |
Minority Interest in Earnings | 49.19 | 41.6 | 53.3 | 95.82 | 14.54 |
Net Income | -256.6 | -443.22 | -373.09 | -541.4 | -816.59 |
Net Income to Common | -256.6 | -443.22 | -373.09 | -541.4 | -816.59 |
Shares Outstanding (Basic) | 748 | 715 | 665 | 479 | - |
Shares Outstanding (Diluted) | 748 | 715 | 665 | 479 | - |
Shares Change (YoY) | 4.53% | 7.64% | 38.63% | - | - |
EPS (Basic) | -0.34 | -0.62 | -0.56 | -1.13 | - |
EPS (Diluted) | -0.34 | -0.62 | -0.56 | -1.13 | - |
Free Cash Flow | -259.18 | -500.12 | 331.31 | -175.67 | -325.96 |
Free Cash Flow Per Share | -0.35 | -0.70 | 0.50 | -0.37 | - |
Gross Margin | 6.96% | -17.32% | -12.08% | -30.20% | -10.01% |
Operating Margin | -40.98% | -94.67% | -66.24% | -99.50% | -93.53% |
Profit Margin | -55.79% | -114.14% | -69.26% | -114.66% | -173.56% |
Free Cash Flow Margin | -56.35% | -128.80% | 61.51% | -37.20% | -69.28% |
EBITDA | -63.88 | -259.85 | -241.21 | -355.52 | -356.26 |
EBITDA Margin | -13.89% | -66.92% | -44.78% | -75.29% | -75.72% |
D&A For EBITDA | 124.6 | 107.75 | 115.58 | 114.29 | 83.79 |
EBIT | -188.47 | -367.6 | -356.79 | -469.8 | -440.05 |
EBIT Margin | -40.98% | -94.67% | -66.24% | -99.50% | -93.53% |